The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 11,600 |
| Depreciation and amortization | 7,624 |
| Deferred income taxes | 2,453 |
| Reserve for uncertain tax positions | 174 |
| Loss on disposal of property and equipment | -61 |
| Non-cash share-based compensation expense | 3,312 |
| Change in fair value of contingent consideration | 141 |
| Loss on extinguishment of debt | -67 |
| Amortization of debt issuance costs | 102 |
| Trade accounts receivable | 53 |
| Prepaid expenses and other current and noncurrent assets | -24 |
| Operating lease assets and liabilities, net | 41 |
| Deferred contract costs, net | 936 |
| Accounts payable | 170 |
| Accrued expenses, wages and bonuses | 1,670 |
| Income taxes receivable and payable | -191 |
| Deferred revenue | 273 |
| Net cash provided by operating activities | 26,450 |
| Capital expenditures | 10,706 |
| Acquisitions, net of cash acquired | 0 |
| Proceeds from the sale of property and equipment | 0 |
| Net cash used in investing activities | -10,706 |
| Borrowings on notes payable | 31,424 |
| Payment of debt issuance costs | 134 |
| Payments on notes payable | 47,681 |
| Borrowings on revolving loan | 37,000 |
| Payments on revolving loan | 37,003 |
| Payments on finance lease obligations | 9 |
| Proceeds from the exercise of stock options | 132 |
| Payment of payroll tax withholdings on share-based awards exercised | 407 |
| Payment of acquisition contingent consideration | 516 |
| Repurchase of shares for treasury | 20,180 |
| Payment of dividends on common stock | 10,978 |
| Net cash used in financing activities | -15,838 |
| Effect of exchange rate changes on cash | 0 |
| Change in cash and cash equivalents | -94 |
| Cash and cash equivalents at beginning of period | 4,233 |
| Cash and cash equivalents at end of period | 4,139 |
NATIONAL RESEARCH CORP (NRC)
NATIONAL RESEARCH CORP (NRC)